|
GSG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.54871728961371E-15 |
| Normal-vs-Stage2 |
1.56399999995394E-06 |
| Normal-vs-Stage3 |
7.31570004575133E-09 |
| Normal-vs-Stage4 |
1.22290000004188E-06 |
| Stage1-vs-Stage2 |
8.486000E-01 |
| Stage1-vs-Stage3 |
7.296000E-02 |
| Stage1-vs-Stage4 |
2.035900E-03 |
| Stage2-vs-Stage3 |
1.118560E-01 |
| Stage2-vs-Stage4 |
2.439200E-03 |
| Stage3-vs-Stage4 |
2.644500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.18870000001647E-06 |
| Normal-vs-Asian |
8.521800E-02 |
| Caucasian-vs-AfricanAmerican |
2.246300E-02 |
| Caucasian-vs-Asian |
2.759600E-01 |
| AfricanAmerican-vs-Asian |
2.647600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62592161956354E-12 |
| Normal-vs-Female |
7.89368570508486E-14 |
| Male-vs-Female |
7.196100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.411200E-04 |
| Normal-vs-Age(41-60Yrs) |
7.49023065793608E-12 |
| Normal-vs-Age(61-80Yrs) |
5.60662627435704E-14 |
| Normal-vs-Age(81-100Yrs) |
4.803200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.607600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.111400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.998400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.993000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.882910E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.961800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.318900E-03 |
| Normal-vs-Grade 2 |
1.17683640610267E-14 |
| Normal-vs-Grade 3 |
5.6621374255883E-15 |
| Normal-vs-Grade 4 |
3.29759999995183E-06 |
| Grade 1-vs-Grade 2 |
2.765000E-01 |
| Grade 1-vs-Grade 3 |
8.875900E-03 |
| Grade 1-vs-Grade 4 |
6.416700E-04 |
| Grade 2-vs-Grade 3 |
8.520800E-03 |
| Grade 2-vs-Grade 4 |
1.699980E-03 |
| Grade 3-vs-Grade 4 |
1.220460E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.70508052121932E-12 |
| Normal-vs-ccB subtype |
1.44919631850371E-11 |
| ccA subtype-vs-ccB subtype |
3.646200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.96458471291817E-12 |
| Normal-vs-N1 |
1.103760E-03 |
| N0-vs-N1 |
8.515200E-03 |
|
|
